Source: IRS Employment Review Issue: 887 Date: 12/12/2007 Publisher: IRS

Table 1b: Profile of long-term sickness absence in autumn 2007 - named practice for employers in the manufacturing and production sector


In this table:
Chemicals and pharmaceuticals
Construction
Electricity, gas and water
Engineering and metals
Food, drink and tobacco
General manufacturing
Mining and quarrying
Paper and printing
Textiles

Table 1a: Profile of long-term sickness absence in autumn 2007 - named practice for employers in private sector services

Table 1c: Profile of long-term sickness absence in autumn 2007 - named practice for employers in the public sector

Back to main article

Chemicals and pharmaceuticals

Employer
(employee nos.)1

Estimated annual cost of long-term absences

No. of employees currently on long-term absence

Most effective means of managing long-term absence

Barloworld Scientific (300) (S)

-

7 (actual)

HR

Boots Manufacturing (1,300) (W)

£2 million

50 (approx.)

Line manager

Constar International UK (180) (W)

£50,000

3 (actual)

Occupational health/company physician

GR Land Health Products (150) (W)

£70,000

3 (actual)

-

Huntingdon Life Sciences (1,200) (W)

£1.25 million

-

Line manager

Intervet UK (285) (W)

£40,000

1 (actual)

External occupational health service

Perrigo (720) (W)

£94,000 in sick pay.

To read the rest of this article you must login
Existing users login here

Compliance

Keep on the right side
of employment law

Good Practice

Engage your people to
achieve your objectives

Benchmarking

Measure, monitor and
match best practices
 

For more information on XpertHR call 020 8652 4653 or email enquiries@xperthr.co.uk









irs
personnel today
lexisNexis


© Reed Business Information Ltd  Terms & Conditions |  Privacy Policy

XpertHR is designed to work consistently across a range of browsers, including Internet Explorer,
Mozilla Firefox, Opera and Safari. If you find bugs in our site, please contact us. We appreciate feedback.





This Item:

Save

Email

Print